Skip to content
healthcare.dev
Get a free key

STRENSIQ

NDC 25682-013, ASFOTASE ALFA, solution, from Alexion Pharmaceuticals, Inc..

Product NDC
25682-013
Status
Listed
Labeler
Alexion Pharmaceuticals, Inc.
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125513
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25682-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASFOTASE ALFA28 mg/.7mL

Pharmacologic classes

Alkaline Phosphatase [CS]; Tissue-nonspecific Alkaline Phosphatase [EPC]

Package NDCNDC-11Package
25682-013-122568200131212 VIAL in 1 CARTON (25682-013-12) / .7 mL in 1 VIAL (25682-013-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3387574f-5eaa-4501-a71d-4cbfbd563031

Use it

Look up 25682-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25682-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25682-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.